Clinical Trials · NCT00275262
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Abbott
- Enrollment
- 25
- Start date
- Feb 2006
- Locations
- 4 sites, United States
- Primary endpoint
- Mean Change From Baseline in IgM Response (Mcg/mL) Before Keyhole Limpet Hemocyanin (KLH) Vaccination at Month 6 and After KLH Vaccination at Month 7 in Patients Who Received LAD or Placebo